However, leukemia stem cells (LSCs) are resistant to specific TKIs and cause disease relapse after drug discontinuation in CML, besides, CTL transfer therapy leads to upregulation of PD-L1 on LSCs, which protects LSCs from CTL-mediated elimination. The gene discussed is CD274; the disease is leukemia.